ADMINISTRATION CONTINUE D'INHIBITEURS DE LA L-DOPA DECARBOXYLASE, D'INHIBITEURS DE LA DOPA DECARBOXYLASE, ET D'INHIBITEURS DE LA CATECHOL-O-METHYLE TRANSFERASE； ET COMPOSITIONS CORRESPONDANTES
Provided herein, in part, is a method of treating a neurological or movement disorder in a patient in need thereof, comprising subcutaneously administering to said patient a pharmaceutically acceptable composition comprising levodopa and optionally carbidopa and optionally entacapone or tolcapone, or pharmaceutically acceptable salts thereof, wherein said composition is administered substantially continuously, and compositions that can be used in the disclosed methods.
